Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma

Surgery

Volumn 150, Issue 6, 2011, Pages 1168-1177

  Yip, Dana T ^a   Hassan, Maria ^a   Pazaitou Panayiotou, Kalliopi ^a   Ruan, Daniel T ^b   Gawande, Atul A ^b   Gaz, Randall D ^a   Moore Jr , Francis D ^b   Hodin, Richard A ^a   Stephen, Antonia E ^a   Sadow, Peter M ^a   Daniels, Gilbert H ^a   Randolph, Gregory W ^c   Parangi, Sareh ^a   Lubitz, Carrie C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CARCINOEMBRYONIC ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CALCITONIN BLOOD LEVEL; CANCER STAGING; CHILD; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CALCITONIN; CARCINOEMBRYONIC ANTIGEN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOPLASTIC SYNDROMES, HEREDITARY; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 82755182447     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2011.09.043     Document Type: Article

References (27)

1. L. Enewold, K. Zhu, and E. Ron Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005 Cancer Epidemiol Biomarkers Prev 18 2009 784 791
2. R.T. Kloos, C. Eng, and D.B. Evans Medullary thyroid cancer: management guidelines of the American Thyroid Association Thyroid 19 2009 565 612
3. M.A. Kouvaraki, S.E. Shapiro, and B.D. Fornage Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer Surgery 134 2003 946 954
4. E. Kebebew, S. Kikuchi, Q.Y. Duh, and O.H. Clark Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer Arch Surg 135 2000 895 901 (Pubitemid 30625965)
5. B. Panigrahi, S.A. Roman, and J.A. Sosa Medullary thyroid cancer: are practice patterns in the United States discordant from American Thyroid Association guidelines? Ann Surg Oncol 17 2010 1490 1498
6. J. Barbet, L. Campion, F. Kraeber-Bodere, and J.F. Chatal Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma J Clin Endocrinol Metab 90 2005 6077 6084 (Pubitemid 41606528)
7. R. Cohen, J.M. Campos, and C. Salaun Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC) J Clin Endocrinol Metab 85 2000 919 922 (Pubitemid 32273687)
8. T. Weber, T. Schilling, and K. Frank-Raue Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas Surgery 130 2001 1044 1049 (Pubitemid 34014572)
9. A. Machens, U. Schneyer, H.J. Holzhausen, and H. Dralle Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level J Clin Endocrinol Metab 90 2005 2029 2034 (Pubitemid 40586235)
10. R.S. Sippel, M. Kunnimalaiyaan, and H. Chen Current management of medullary thyroid cancer Oncologist 13 2008 539 547 (Pubitemid 351872871)
11. M.R. Pelizzo, I.M. Boschin, and P. Bernante Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients Eur J Surg Oncol 33 2007 493 497 (Pubitemid 46586095)
12. E. Modigliani [Type 2 endocrine neoplasms. Clinical aspects] Presse Med 27 1998 628 632
13. S. Grozinsky-Glasberg, C.A. Benbassat, and G. Tsvetov Medullary thyroid cancer: a retrospective analysis of a cohort treated at a single tertiary care center between 1970 and 2005 Thyroid 17 2007 549 556 (Pubitemid 47068118)
14. C. Romei, S. Mariotti, and L. Fugazzola Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes Eur J Endocrinol 163 2010 301 308
15. E. Skoura, P. Rondogianni, and M. Alevizaki Role of [(18)F]FDG-PET/CT in the detection of occult recurrent medullary thyroid cancer Nucl Med Commun 31 2010 567 575
16. A.L. Giraudet, D. Vanel, and S. Leboulleux Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels J Clin Endocrinol Metab 92 2007 4185 4190 (Pubitemid 350074730)
17. J.W. de Groot, T.P. Links, W.J. Sluiter, B.H. Wolffenbuttel, T. Wiggers, and J.T. Plukker Locoregional control in patients with palpable medullary thyroid cancer: results of standardized compartment-oriented surgery Head Neck 29 2007 857 863 (Pubitemid 350303674)
18. J.F. Moley, and M.K. DeBenedetti Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection Ann Surg 229 1999 880 887
19. M.D. Leggett, S.L. Chen, P.D. Schneider, and S.R. Martinez Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma Ann Surg Oncol 15 2008 2493 2499
20. A. Machens, and H. Dralle Biomarker-based risk stratification for previously untreated medullary thyroid cancer J Clin Endocrinol Metab 95 2010 2655 2663
21. E. Modigliani, R. Cohen, and J.M. Campos Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'etude des tumeurs a calcitonine Clin Endocrinol (Oxf) 48 1998 265 273 (Pubitemid 28137636)
22. C. Scollo, E. Baudin, and J.P. Travagli Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer J Clin Endocrinol Metab 88 2003 2070 2075 (Pubitemid 36549878)
23. F. Pacini, M. Schlumberger, H. Dralle, R. Elisei, J.W. Smit, and W. Wiersinga European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium Eur J Endocrinol 154 2006 787 803 (Pubitemid 43997716)
24. R. Elisei, V. Bottici, and F. Luchetti Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders J Clin Endocrinol Metab 89 2004 163 168 (Pubitemid 38183876)
25. F. Pacini, M. Fontanelli, and L. Fugazzola Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma J Clin Endocrinol Metab 78 1994 826 829 (Pubitemid 24118072)
26. K. Cheung, S.A. Roman, T.S. Wang, H.D. Walker, and J.A. Sosa Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis J Clin Endocrinol Metab 93 2008 2173 2180 (Pubitemid 351831532)
27. G. Costante, C. Durante, Z. Francis, M. Schlumberger, and S. Filetti Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls Nat Clin Pract Endocrinol Metab 5 2009 35 44